Nureca Limited Buyback 2025
1. Healthcare & Wellness Products Company
Nureca Limited is a B2C healthcare and wellness brand offering products across medical devices, nutrition, lifestyle, orthopedic care, and mother & baby wellness segments.
2. Strong Digital-First Distribution Model
The company is known for its online-first strategy, selling primarily through leading e-commerce platforms such as Amazon, Flipkart, Nykaa, 1mg, as well as its own D2C website “Dr Trust”.
3. Popular Consumer Brands
Nureca owns strong consumer-facing brands like Dr Trust, Dr Physio, and Trumom, widely recognized for affordability and quality in home healthcare products.
4. Focus on Home Healthcare Devices
Core product categories include BP monitors, oximeters, nebulizers, TENS machines, smart scales, orthopedic supports, and fitness devices—addressing rising demand for home diagnostics.
5. Asset-Light Business Model
The company follows an asset-light approach, outsourcing manufacturing while focusing on branding, product design, R&D, and digital marketing to maintain scalability and high margins.
6. Riding the Preventive Healthcare Trend
With increasing awareness of preventive health, chronic disease monitoring, and post-pandemic adoption of home diagnostics, Nureca is well-positioned to capitalize on long-term growth in India’s consumer healthcare market.
Buy Back Offer Deal:
| Buyback Type: | Tender Offer |
| Buyback Record Date: | Dec 12 2025 |
| Buyback Opening Date: | Dec 18 2025 |
| Buyback Closing Date: | Dec 24 2025 |
| Buyback Offer Amount: | ₹ 19.14 Cr. |
| Date of Board Meeting approving the proposal: | Nov 28 2025 |
| Date of Public Announcement: | Nov 28 2025 |
| Buyback Offer Size: | 5.79% |
| Buyback Number of Shares: | 5,80,000 |
| FV: | 10 |
| Buyback Price: | ₹ 330 Per Equity Share |
Details of Buyback:
Salient financial parameters:
| Particulars (in cr) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
| Sales + | 213 | 256 | 111 | 92 | 110 |
| Expenses + | 152 | 200 | 126 | 102 | 117 |
| Operating Profit | 62 | 56 | -15 | -10 | -8 |
| OPM % | 29% | 22% | -13% | -11% | -7% |
| Other Income + | 3 | 8 | 7 | 11 | 12 |
| Interest | 2 | 1 | 0 | 0 | 1 |
| Depreciation | 0 | 1 | 2 | 2 | 2 |
| Profit before tax | 62 | 61 | -11 | -3 | 1 |
| Tax % | 26% | 26% | -23% | -30% | 37% |
| Net Profit + | 46 | 45 | -8 | -2 | 1 |
| EPS in Rs | 46.37 | 44.96 | -8.25 | -1.79 | 0.85 |
| Dividend Payout % | 4% | 7% | 0% | 0% | 0% |
How to Participate in buyback?
26 Comments
Leave a Reply
You must be logged in to post a comment.
contract note recieved of 100% shares
0.8x subscription recieved..100%AR expected… easy 10% return… only catch is your whole return is deducted as tds which will be refunded after 7-8months
Can we fill form 15G to save tds in case of buybacks ?
we have to fill it and send them during tendering period.. the form was not attached to Offer letter so i called them asking them to send me… they said mail it and we will send you.. i never recieved the reply from them… so ig tds will be deducted and i am gonna have to wait for 7-8 months for refund… clearly the managers and registrars are negligant towards form 15s
ER SAME FOR BOTH CATEGORIES…126 Equity Share for every 761 Equity Share
Matromony Limited approves Proposal of buyback of 8,93,129 fully paid-up equity shares of an amount not exceeding ₹ 58.5 Crores at a buyback price of ₹655, subject to the approval of shareholders by way of a special resolution through a postal ballot
Nectar Lifesciences Ltd proposed a buyback for Rs81crore at Rs27 per share, an aggrigate of 13.38% of whole company, which promoters not participating at all… that means public which holds 54.37% of company give away 13.38%… good AR expected with a wooping 50% premium over CMP….record date being December 24, 2025… price will definately move tomorrow
Aditya ji source of this news cos not finding it anywhere else
BSE exchange fillings provides fastest infornmation
It is a penny stock with more than 98% of meagre 15 % promoters holding in pledge. Has been consistently making losses .Wonder where has it got 84 crore for the proposed buyback!
Is it worth taking the risk ?
As per the Last Annual Report Board of Directors stated that,
The company is selling its entire API business for ₹1,270 crore + menthol unit sale for ₹20 crore.
Management has stated that proceeds will be used for:
1.Repayment of debt
2.Investment in new businesses
3.Special dividend / Buyback
4.General corporate purposes
Company has total Borrowing as on 31.03.2025 – Nearly 570 Crores
Promotors Shares Pledged
After API Business is sold company will no longer in core Business and also management has not committed to any particular business vertical yet to start with…
Thank you, Rajit Parikh ji for the update. Excellent as usual.
i think we are traders who want to profit from a buyback and i think it is a good opportunity considering the buyback size and premium.. if the price hit UC tomorrow, will make it less lucrative
Hello sir, I have a question that can we buy it for more than 2.0 lacs to enter in general category as promotor is not participating and FII and DII are very small and 85% will be reserved for general category so may be acceptance ratio for general category remains high as HNI people generally avoid buyback due to tax calculation and assuming that most people having stocks of more than 2.0 lacs would be HNI
we can try that… but i am afraid to put 2L in this stock… I am expecting a min 50% AR but no onecan be sure… if you have that risk apetite, you can surely do that
Today it is trading in range.what should be range for buyback
since promoters aren’t participating, should we apply in general category or retail ?
there were no seller at 290. today at 300 if you buy, essentially you pay 33rs per share tds which can be claimed as refund given you donot fall under taxable category. biggest assumption being 100% AR
Company has total Borrowing as on 31.03.2025 – Nearly 570 Crores
Promotors Shares Pledged
After API Business is sold company will no longer in core Business and also management has not committed to any particular business vertical yet to start with…
i made this comment for nureca limited… with premium being less than 10%, i think 100% AR can be expected
bro i want your guidance can i talk?
sure… insta theadityaagrawal
Buy @290 today .on 100 % acceptance pay 33 rs to government as tds then also we can earn 7 rs per share .brokerage not considered.
Only 15G OR 15H Save you if you are eligible.
hi girish in which buyback you joining nurea or nectar? tell me ar ratio of both